KITVAY
Live / Applied — Extension of time to oppose received (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 26 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99254091
- Mark type
- Stylized text
- Filed
- 26 Jun 2025
- Published for opposition
- 14 Oct 2025
- Attorney of record
- Gabriel M. Gillmeyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
Owner
- Cogent Biosciences, Inc., Waltham, MA, US
- Cogent Biosciences, Inc., Waltham, MA, US
Prosecution history
- 02 Apr 2026 — WITHDRAWN FROM ISSUE-TTAB REQUEST
- 27 Mar 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 11 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Jan 2026 — NON-FINAL ACTION E-MAILED
- 31 Jan 2026 — NON-FINAL ACTION WRITTEN
- 30 Jan 2026 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 11 Nov 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 14 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Oct 2025 — PUBLISHED FOR OPPOSITION
- 08 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Sept 2025 — ASSIGNED TO EXAMINER